SYRS - Syros Pharmaceuticals EPS beats by $0.01 beats on revenue November, 12 2019 08:03 AM Syros Pharmaceuticals Inc. Syros Pharmaceuticals (NASDAQ:SYRS): Q3 GAAP EPS of -$0.47 beats by $0.01.More news on: Syros Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...